Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Trading Update

14 Jul 2020 07:00

RNS Number : 8668S
DX (Group) PLC
14 July 2020
 

14 July 2020

AIM: DX.

DX (Group) plc

("DX" or "the Group" or "the Company")

 

Trading Update

 

DX, a leading provider of delivery solutions, including parcel freight, secure, courier and logistics services, is pleased to provide an update on trading for the 52 weeks ended 27 June 2020. As an essential service provider, DX continued to maintain operations at all of its depots and service centres after the UK Government's COVID-19 'lockdown' measures came into effect, with the health and safety of all employees and customers remaining paramount.

 

Since the Company's last update on 28 May 2020, trading in both the Freight and Express divisions has continued to improve, and Group revenue for June was only 3% below previous forecast levels (set prior to the COVID-19 pandemic). This improved performance across both divisions mainly reflects recovery in volumes from existing customers but also some new business wins.

 

As a result, the Board expects that revenue and adjusted EBITDA for the full year (both on an IAS17 and IFRS16 basis) will be in line with current market forecasts1 and that the Company will report an adjusted pre-tax profit2 on an IAS17 basis. This will be DX's first full year adjusted pre-tax profit since the current management team initiated its turnaround plan for the business in spring 2018. The net cash position of £12.3m at the year-end (2019: net debt of £1.3m), was better than market expectations, although it has benefited from payment deferrals of £11.9m in total, including VAT and other agreed payment holidays.

 

Volumes are continuing to rise, supported by strong levels of customer service. Both divisions are experiencing a business mix slightly more weighted to B2C than previously anticipated. The Company's £10.0m capital investment programme, to be completed over the course of FY20 and FY21, is progressing as planned.

 

Full year results are expected to be announced in late September.

 

Ronald Series, Chairman of DX, commented:

 

"Having launched our turnaround plan two and a half years ago, we are delighted to report the Company's expected return to adjusted pre-tax profit. It demonstrates the hard work, expertise and resilience of our people. We have a clear vision for ongoing growth and remain wholly focused on the next stage of the Company's development."

 

 

Notes

 

Note 1

The Board believes that the consensus market estimate for revenue for the financial year ending 27 June 2020 prior to this announcement was £326.7m and that the estimate for adjusted EBITDA was £3.4m (IAS 17 basis) and £24.0m (IFRS 16 basis)

 

Note 2

Adjusted pre-tax profit excludes share-based payments and amortisation of acquired intangibles. Prior to this announcement the market estimates of adjusted pre-tax profit were a loss of £0.9m (IFRS16 basis) and a profit of £0.4m (IAS17 basis)

 

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Enquiries:

DX (Group) plc

T: 020 3178 6378 (c/o KTZ

Ronald Series, Chairman

 Communications)

Lloyd Dunn, Chief Executive Officer

David Mulligan, Chief Financial Officer

finnCap (Nominated Adviser and Joint Broker to DX)

T: 020 7220 0500

Matt Goode/Simon Hicks/Hannah Boros (Corporate Finance)

Andrew Burdis/Camille Gochez (ECM)

Liberum (Joint Broker to DX)

T: 020 3100 2000

Robert Morton/Euan Brown/William Hall

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis

Dan Mahoney

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGPURWMUPUGAW
Date   Source Headline
26th Oct 202012:36 pmRNSDirector Share Purchase
21st Oct 20207:00 amRNSDX Expands Depot Network with New Burnley Site
19th Oct 20208:50 amRNSNotice of AGM and Annual Report and Accounts
16th Oct 202012:23 pmRNSHolding(s) in Company
14th Oct 20203:05 pmRNSAppointment of Auditor
29th Sep 20207:00 amRNSDirector Share Purchase
28th Sep 20208:23 amRNSDirector Share Purchase
21st Sep 202012:08 pmRNSDirector Share Purchase
18th Sep 202011:24 amRNSDirector Share Purchase - Replacement
17th Sep 20204:31 pmRNSDirector Share Purchase
17th Sep 20207:00 amRNSPreliminary Results
10th Sep 20207:50 amRNSExpands depot network with two new sites
14th Jul 20207:00 amRNSTrading Update
9th Jul 20207:00 amRNSJoins consortium to deliver COVID-19 testing kits
3rd Jul 20204:36 pmRNSHolding(s) in Company
2nd Jul 20202:06 pmRNSSecond Price Monitoring Extn
2nd Jul 20202:00 pmRNSPrice Monitoring Extension
2nd Jul 20208:00 amRNSPDMR Share Purchase
1st Jul 202011:35 amRNSDirector Share Purchase
30th Jun 20204:17 pmRNSDirector Share Purchase
29th Jun 20209:06 amRNSDirector Share Purchase
15th Jun 20207:00 amRNSDirector Share Purchase
8th Jun 20207:00 amRNSLaunching an Expanded DX Express Centre in Ipswich
5th Jun 20207:00 amRNSDirector Share Purchase
29th May 202012:11 pmRNSDirector/PDMR Shareholding
28th May 20204:07 pmRNSCompany Secretary Share Purchase
28th May 20207:00 amRNSTrading Update
27th Apr 202010:27 amRNSDirector Share Purchase
17th Apr 20202:15 pmRNSDirector Share Purchase
16th Apr 20207:00 amRNSTrading and Coronavirus Update
1st Apr 20207:00 amRNSHolding(s) in Company
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
19th Mar 20207:00 amRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSAppointment of Joint Broker
3rd Mar 20207:00 amRNSInterim Results
24th Feb 20207:00 amRNSNotice of Interim Results
4th Feb 20207:00 amRNSTrading update
3rd Jan 202012:40 pmRNSHolding(s) in Company
28th Nov 201912:38 pmRNSResult of AGM
28th Nov 20197:00 amRNSAGM Statement
15th Oct 201912:41 pmRNSReplacement: Notice of AGM
15th Oct 20198:06 amRNSNotice of AGM
24th Sep 20197:00 amRNSPreliminary Results
23rd Jul 20197:00 amRNSPre-close Trading Update
3rd Jul 20191:30 pmRNSDirector/PDMR Shareholding
29th May 20194:35 pmRNSPrice Monitoring Extension
28th May 20197:00 amRNSHMPO Contract and Trading Update
16th Apr 201912:41 pmRNSDirector/PDMR Shareholding
26th Mar 20195:52 pmRNSHolding(s) in Company
5th Mar 20197:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.